Ryan B. Corcoran
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 45
- Pancreatic and Hepatic Oncology Research 12
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 44
- Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer 20
- Molecular Biology top 1%
- Melanoma and MAPK Pathways 25
- PI3K/AKT/mTOR signaling in cancer 8
-
- Lung Cancer Treatments and Mutations 20
- Gastric Cancer Management and Outcomes 9
- Co-authors
- Jeffrey A. EngelmanBruce A. ChabnerKevin D. CourtneyMatthew P. ScottJeffrey SettlemanRona YaegerMeagan B. RyanArnold J. Levine
- Journals
- Journal of Clinical Oncology (38 papers)Cancer Research (13 papers)Annals of Oncology (12 papers)
- Partner nations
- United StatesItalyJapan
In The Last Decade
Ryan B. Corcoran
125 papers receiving 7.9k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Oncology 3.7k
- Cancer Research 2.1k
- Pathology and Forensic Medicine 1.6k
- Molecular Biology 4.9k
- Pulmonary and Respiratory Medicine 1.7k
Countries citing papers authored by Ryan B. Corcoran
This map shows the geographic impact of Ryan B. Corcoran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan B. Corcoran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan B. Corcoran more than expected).
Fields of papers citing papers by Ryan B. Corcoran
This network shows the impact of papers produced by Ryan B. Corcoran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan B. Corcoran. The network helps show where Ryan B. Corcoran may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ryan B. Corcoran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 10 | |
| 2 | 2024 | 23 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 38 | |
| 6 | 2022 | 76 | |
| 7 | Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivationbreakdown → | 2021 | 302 |
| 8 | 2021 | 18 | |
| 9 | 2020 | 70 | |
| 10 | 2020 | 15 | |
| 11 | 2019 | 62 | |
| 12 | 2019 | 85 | |
| 13 | 2017 | 196 | |
| 14 | 2015 | 138 | |
| 15 | 2015 | 27 | |
| 16 | 2014 | 103 | |
| 17 | 2013 | 110 | |
| 18 | EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenibbreakdown → | 2012 | 767 |
| 19 | 2011 | 334 | |
| 20 | 2006 | 251 |
About Ryan B. Corcoran
Ryan B. Corcoran is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 132 papers that have together received 8.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (45 papers), Cancer Genomics and Diagnostics (44 papers), Melanoma and MAPK Pathways (25 papers), Lung Cancer Treatments and Mutations (20 papers), Genetic factors in colorectal cancer (20 papers), Pancreatic and Hepatic Oncology Research (12 papers), Gastric Cancer Management and Outcomes (9 papers) and PI3K/AKT/mTOR signaling in cancer (8 papers). The work is most often cited by research in Oncology (3.7k citations), Cancer Research (2.1k citations), Pathology and Forensic Medicine (1.6k citations), Molecular Biology (4.9k citations) and Pulmonary and Respiratory Medicine (1.7k citations). Ryan B. Corcoran has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include Jeffrey A. Engelman, Bruce A. Chabner, Kevin D. Courtney, Matthew P. Scott, Jeffrey Settleman, Rona Yaeger, Meagan B. Ryan, Arnold J. Levine, Diane Pennica and Lifeng Xu. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Clinical Cancer Research and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.